October 11, 2018
Revenues at constant exchange rates up 8.8% in third quarter of 2018 to EUR 364.4m Adjusted EBITDA at constant exchange rates—excluding Sensile Medical and...
More October 11, 2018
Duesseldorf, October 11, 2018—Andreas Schütte (56) will step down from the Management Board of Gerresheimer AG at his own request as of February 28, 2019 in...
More September 27, 2018
Duesseldorf/Olten, September 27, 2018 – A wearable micro pump from Sensile Medical has received EU certification for the European market. A European pharma...
More September 06, 2018
Dietmar Siemssen to assume as Chief Executive Officer on November 1, 2018. Previously held position as Stabilus CEO. Speaker of the Management Board and CFO...
More July 11, 2018
With the acquisition of Sensile Medical, Gerresheimer is extending its business model in the direction of an Original Equipment Manufacturer (OEM) for drug...
More April 25, 2018
Duesseldorf, April 25, 2018 – The distribution of a dividend of EUR 1.10 per share was approved at the Annual General Meeting of Gerresheimer AG held today in...
More April 12, 2018
Revenues at constant exchange rates EUR 299.2m in first quarter of 2018, as expected, stable relative to prior-year period; organic revenue growth 0.4% ...
More February 22, 2018
Fourth-quarter revenues up 4.7%, with organic growth of 6.7%. Slight 2.0% decrease for full year 2017 to EUR 1,348.3m. Revenues at constant exchange rates...
More February 05, 2018
Dr. Christian Fischer, Chairman of the Management Board of Gerresheimer AG, will leave the Company with immediate effect. Dr. Fischer has asked for an amicable...
More 